1,739 XNAS Volume
XNAS 19 Mar, 2025 12:58 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jakob Dupont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 16,984 | 16,984 | - | - | Stock Option (Right to Buy) | |
| Jakob Dupont | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Grant A. Yonehiro | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 155,000 | 155,000 | - | - | Stock Option (Right to Buy) | |
| William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 440,000 | 440,000 | - | - | Stock Option (Right to Buy) | |
| Sarah Nemec | VP, Finance and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sarah Nemec | VP, Finance and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Kathleen D. Laporte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Mahendra Gopaldas Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Nicole Onetto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Frank D. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Laura Berner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Grant A. Yonehiro | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Randall C. Schatzman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 654,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Edith A. Perez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Grant Yonehiro A. | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 31 Dec 2023 | 2,500 | 8,918 | - | 0.8 | 1,955 | Common Stock |
| Edith A. Perez | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 31 Dec 2023 | 2,500 | 46,612 | - | 0.8 | 1,955 | Common Stock |
| A. Perez Edith | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 31 Dec 2023 | 2,070 | 44,112 | - | 1.2 | 2,446 | Common Stock |
| C. Randall Schatzman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 31 Dec 2023 | 2,500 | 12,859 | - | 0.8 | 1,955 | Common Stock |
| Randall C. Schatzman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 31 Dec 2023 | 2,500 | 10,359 | - | 1.2 | 2,954 | Common Stock |
| P. Quinn William | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 12 Dec 2023 | 1,829 | 26,272 | - | 1.2 | 2,161 | Common Stock |
| P. William Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 12 Dec 2023 | 2,500 | 28,772 | - | 0.8 | 1,955 | Common Stock |
| P. William Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 12 Dec 2023 | 7,500 | 36,272 | - | 1.0 | 7,125 | Common Stock |
| Grant A. Yonehiro | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 228,000 | 228,000 | - | - | Stock Option (Right to Buy) | |
| Randall C. Schatzman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 728,270 | 728,270 | - | - | Stock Option (Right to Buy) | |
| William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Edith A. Perez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Grant A. Yonehiro | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 31 Dec 2022 | 2,500 | 3,918 | - | 1.6 | 4,101 | Common Stock |
| Grant A. Yonehiro | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 31 Dec 2022 | 2,500 | 6,418 | - | 1.2 | 2,954 | Common Stock |
| Randall C. Schatzman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 31 Dec 2022 | 2,500 | 7,859 | - | 1.2 | 2,954 | Common Stock |
| Randall C. Schatzman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 31 Dec 2022 | 2,500 | 5,359 | - | 1.6 | 4,101 | Common Stock |
| William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 31 Dec 2022 | 1,789 | 24,443 | - | 1.2 | 2,114 | Common Stock |
| William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 31 Dec 2022 | 2,500 | 22,654 | - | 1.6 | 4,101 | Common Stock |
| Edith A. Perez | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 31 Dec 2022 | 2,500 | 39,542 | - | 1.6 | 4,101 | Common Stock |
| Edith A. Perez | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 31 Dec 2022 | 2,500 | 42,042 | - | 1.2 | 2,954 | Common Stock |
| Kathleen D. Laporte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Richard A. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Laura Berner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Laura Berner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 12,261 | 12,261 | - | - | Stock Option (Right to Buy) | |
| Kathleen D. Laporte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Mahendra Gopaldas Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Nicole Onetto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Richard A. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Edgar G. Engleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Frank D. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Kathleen D. Laporte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Mahendra Gopaldas Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Nicole Onetto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 12,227 | 12,227 | - | - | Stock Option (Right to Buy) | |
| Nicole Onetto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 22,140 | 22,140 | - | - | Stock Option (Right to Buy) | |
| Richard A. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 14,071 | 14,071 | - | - | Stock Option (Right to Buy) | |
| Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 22,140 | 22,140 | - | - | Stock Option (Right to Buy) | |
| Edgar G. Engleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Frank D. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 14,071 | 14,071 | - | - | Stock Option (Right to Buy) | |
| Frank D. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 22,140 | 22,140 | - | - | Stock Option (Right to Buy) | |
| Grant A. Yonehiro | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Randall C. Schatzman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 630,000 | 630,000 | - | - | Stock Option (Right to Buy) | |
| William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) | |
| David Dornan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) | |
| Edith A. Perez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) | |
| Nicole Onetto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 27,860 | 27,860 | - | - | Stock Option (Right to Buy) | |
| William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 16.65 per share. | 08 Dec 2021 | 1,221 | 15,119 | - | 16.7 | 20,330 | Common Stock |
| William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.63 per share. | 08 Dec 2021 | 35 | 15,154 | - | 4.6 | 162 | Common Stock |
| William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.72 per share. | 08 Dec 2021 | 5,000 | 20,154 | - | 4.7 | 23,575 | Common Stock |
| Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 27,860 | 27,860 | - | - | Stock Option (Right to Buy) | |
| Frank D. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 27,860 | 27,860 | - | - | Stock Option (Right to Buy) | |
| Kathleen D. Laporte | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 1,200 | 1,200 | - | 20 | 24,000 | Common Stock |
| Mahendra Gopaldas Shah | Director | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 09 Feb 2021 | 62 | 1,448,286 | - | 20 | 1,240 | Common Stock |
| Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 472,296 | 1,430,637 | - | - | Common Stock | ||
| Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 944,056 | 958,341 | - | - | Common Stock | ||
| Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 17,711 | 0 | - | - | Warrant (Right to Buy) | ||
| Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 472,296 | 0 | - | - | Series B Preferred Stock | ||
| Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 944,056 | 0 | - | - | Series A- 1 Preferred Stock | ||
| Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 17,711 | 1,448,348 | - | 0.1 | 1,240 | Common Stock | |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 450,000 | 2,754,437 | - | 20 | 9,000,000 | Common Stock |
| James I. Healy | Director | 09 Feb 2021 | 1,104,209 | 0 | - | - | Series C-1 Preferred Stock | ||
| James I. Healy | Director | 09 Feb 2021 | 1,200,228 | 0 | - | - | Series C-2 Preferred Stock | ||
| James I. Healy | Director | 09 Feb 2021 | 1,104,209 | 1,104,209 | - | - | Common Stock | ||
| James I. Healy | Director | 09 Feb 2021 | 1,200,228 | 2,304,437 | - | - | Common Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 150,802 | 154,268 | - | - | Common Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 09 Feb 2021 | 144 | 1,821,483 | - | 20 | 2,880 | Common Stock |
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 40,953 | 1,821,627 | - | 0.1 | 2,867 | Common Stock | |
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 1,092,080 | 1,117,184 | - | - | Common Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 317,922 | 1,435,106 | - | - | Common Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 345,568 | 1,780,674 | - | - | Common Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 5,655 | 251,542 | - | 0.1 | 396 | Common Stock | |
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 47,718 | 245,887 | - | - | Common Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 43,901 | 198,169 | - | - | Common Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 175,733 | 1,997,216 | - | 20 | 3,514,660 | Common Stock |
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 5,655 | 0 | - | - | Warrant (Right to Buy) | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 47,718 | 0 | - | - | Series C- 2 Preferred Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 43,901 | 0 | - | - | Series C- 1 Preferred Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 150,802 | 0 | - | - | Series B Preferred Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 40,953 | 0 | - | - | Warrant (Right to Buy) | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 345,568 | 0 | - | - | Series C- 2 Preferred Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 317,922 | 0 | - | - | Series C- 1 Preferred Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 1,092,080 | 0 | - | - | Series B Preferred Stock | ||
| Edgar G. Engleman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 24,267 | 275,789 | - | 20 | 485,340 | Common Stock |
| Edgar G. Engleman | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 09 Feb 2021 | 20 | 251,522 | - | 20 | 400 | Common Stock |
| Randall C. Schatzman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 1,500 | 1,500 | - | 20 | 30,000 | Common Stock |
| William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 1,200 | 13,898 | - | 20 | 24,000 | Common Stock |
| Ashish Siri Ram Khanna | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 1,200 | 1,200 | - | 20 | 24,000 | Common Stock |
| Ashish Siri Ram Khanna | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 1,000 | 1,000 | - | 20 | 20,000 | Common Stock |
| Grant A. Yonehiro | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Randall C. Schatzman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 340,000 | 340,000 | - | - | Stock Option (Right to Buy) | |
| William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| David Dornan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Edith A. Perez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |